Invention Grant
- Patent Title: Hepatitis C virus inhibitors
-
Application No.: US14435047Application Date: 2013-10-31
-
Publication No.: US09598433B2Publication Date: 2017-03-21
- Inventor: Li-Qiang Sun , Eric P. Gillis , Eric Mull , Michael S. Bowsher , Qian Zhao , Paul Michael Scola
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo
- International Application: PCT/US2013/067649 WO 20131031
- International Announcement: WO2014/070964 WO 20140508
- Main IPC: C07D498/04
- IPC: C07D498/04 ; C07K5/083 ; A61K38/20 ; A61K38/21 ; A61K31/4725 ; A61K31/4741 ; A61K31/498 ; A61K45/06 ; C07D519/00
Abstract:
Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Public/Granted literature
- US20150284409A1 Hepatitis C Virus Inhibitors Public/Granted day:2015-10-08
Information query
